Chat with an Alloy clinician and discover weight management options designed for this stage of life
According to a review describing retatrutide as a triple agonist, it targets the GLP-1, GIP, and glucagon receptors together
This approach provides necessary nutrition without causing excessive fullness and can help mitigate muscle loss and potential side effects such as constipation and nausea. At New Jersey Bariatric Center, our registered dietitians create customized meal plans, offer personalized nutrition guidance, and meal prep strategies to help you develop sustainable eating habits while taking weight loss medications
New York, NY (2014)
For the most current Foundayo pricing alongside Mounjaro, Wegovy, and Ozempic, patients are best advised to ask during their consultation, since the figures change
Retatrutide is currently in Phase 3 clinical trials and is not yet approved by Health Canada or the FDA for obesity treatment